

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 6.00379595 |
| 2 | proline metabolic process (GO:0006560) | 4.47702988 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.45616151 |
| 4 | establishment of apical/basal cell polarity (GO:0035089) | 4.33886717 |
| 5 | plasma membrane repair (GO:0001778) | 4.25601607 |
| 6 | transcription from mitochondrial promoter (GO:0006390) | 4.24302264 |
| 7 | sarcomere organization (GO:0045214) | 4.17966859 |
| 8 | carnitine shuttle (GO:0006853) | 4.15946096 |
| 9 | embryonic process involved in female pregnancy (GO:0060136) | 4.12052846 |
| 10 | cardiac myofibril assembly (GO:0055003) | 4.11544102 |
| 11 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.08114627 |
| 12 | regulation of integrin activation (GO:0033623) | 3.99545519 |
| 13 | regulation of protein homooligomerization (GO:0032462) | 3.79225135 |
| 14 | positive regulation of protein homooligomerization (GO:0032464) | 3.73769929 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 3.73337044 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.69309346 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.69309346 |
| 18 | oxidative demethylation (GO:0070989) | 3.68558398 |
| 19 | establishment of monopolar cell polarity (GO:0061162) | 3.67513112 |
| 20 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.67513112 |
| 21 | myofibril assembly (GO:0030239) | 3.56318176 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.54177883 |
| 23 | cardiac muscle contraction (GO:0060048) | 3.51401277 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.46787403 |
| 25 | actin-myosin filament sliding (GO:0033275) | 3.43562093 |
| 26 | muscle filament sliding (GO:0030049) | 3.43562093 |
| 27 | embryonic placenta development (GO:0001892) | 3.43026556 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.28837314 |
| 29 | stress fiber assembly (GO:0043149) | 3.27293151 |
| 30 | cardiac muscle cell development (GO:0055013) | 3.24338872 |
| 31 | protein localization to endosome (GO:0036010) | 3.22271681 |
| 32 | apoptotic process involved in morphogenesis (GO:0060561) | 3.20739785 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.20228974 |
| 34 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.16390375 |
| 35 | tricarboxylic acid cycle (GO:0006099) | 3.15318083 |
| 36 | negative regulation of protein oligomerization (GO:0032460) | 3.14518597 |
| 37 | positive regulation of myotube differentiation (GO:0010831) | 3.11709902 |
| 38 | actomyosin structure organization (GO:0031032) | 3.11547703 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11016219 |
| 40 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.08581561 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.07021897 |
| 42 | membrane tubulation (GO:0097320) | 3.06960419 |
| 43 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.06071109 |
| 44 | cardiac cell development (GO:0055006) | 3.05969766 |
| 45 | regulation of skeletal muscle contraction (GO:0014819) | 3.01498354 |
| 46 | negative regulation of Ras GTPase activity (GO:0034261) | 3.01196105 |
| 47 | carnitine transmembrane transport (GO:1902603) | 2.97517232 |
| 48 | negative regulation of heart growth (GO:0061117) | 2.95088575 |
| 49 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.95088575 |
| 50 | negative regulation of cell size (GO:0045792) | 2.94554616 |
| 51 | cellular response to zinc ion (GO:0071294) | 2.94454584 |
| 52 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.89857627 |
| 53 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.89333729 |
| 54 | detection of other organism (GO:0098543) | 2.87614810 |
| 55 | 2-oxoglutarate metabolic process (GO:0006103) | 2.86304700 |
| 56 | sulfur amino acid catabolic process (GO:0000098) | 2.82683688 |
| 57 | convergent extension (GO:0060026) | 2.81733636 |
| 58 | glycogen catabolic process (GO:0005980) | 2.81283996 |
| 59 | detection of bacterium (GO:0016045) | 2.80669332 |
| 60 | signal complex assembly (GO:0007172) | 2.79993146 |
| 61 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.79065799 |
| 62 | striated muscle contraction (GO:0006941) | 2.79017362 |
| 63 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78657147 |
| 64 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.77642363 |
| 65 | amino-acid betaine transport (GO:0015838) | 2.77020847 |
| 66 | carnitine transport (GO:0015879) | 2.77020847 |
| 67 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.75052346 |
| 68 | mitochondrial DNA metabolic process (GO:0032042) | 2.74064510 |
| 69 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.73273207 |
| 70 | protein heterotrimerization (GO:0070208) | 2.72203609 |
| 71 | anatomical structure regression (GO:0060033) | 2.72010951 |
| 72 | cell communication involved in cardiac conduction (GO:0086065) | 2.71203587 |
| 73 | embryonic camera-type eye development (GO:0031076) | 2.70942312 |
| 74 | regulation of hippo signaling (GO:0035330) | 2.69333009 |
| 75 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.69313152 |
| 76 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.68886959 |
| 77 | actin-mediated cell contraction (GO:0070252) | 2.67626369 |
| 78 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.66492846 |
| 79 | cellular response to epinephrine stimulus (GO:0071872) | 2.65290728 |
| 80 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.64860942 |
| 81 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.64306369 |
| 82 | cell communication by electrical coupling (GO:0010644) | 2.64006887 |
| 83 | fatty acid beta-oxidation (GO:0006635) | 2.63990425 |
| 84 | regulation of p38MAPK cascade (GO:1900744) | 2.63006092 |
| 85 | regulation of cholesterol homeostasis (GO:2000188) | 2.61873420 |
| 86 | mannose metabolic process (GO:0006013) | 2.61292151 |
| 87 | respiratory system process (GO:0003016) | 2.59922335 |
| 88 | regulation of fatty acid oxidation (GO:0046320) | 2.59870125 |
| 89 | epithelial cell-cell adhesion (GO:0090136) | 2.58807899 |
| 90 | regulation of early endosome to late endosome transport (GO:2000641) | 2.58367981 |
| 91 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.58224413 |
| 92 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.57501892 |
| 93 | glucan catabolic process (GO:0009251) | 2.56778925 |
| 94 | mitotic G1/S transition checkpoint (GO:0044819) | 2.56778918 |
| 95 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.56355722 |
| 96 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.55555910 |
| 97 | positive regulation of receptor recycling (GO:0001921) | 2.54926343 |
| 98 | regulation of response to reactive oxygen species (GO:1901031) | 2.54449277 |
| 99 | cardiac muscle hypertrophy (GO:0003300) | 2.53840944 |
| 100 | G1 DNA damage checkpoint (GO:0044783) | 2.53402019 |
| 101 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.53324920 |
| 102 | regulation of protein oligomerization (GO:0032459) | 2.52508650 |
| 103 | regulation of ARF protein signal transduction (GO:0032012) | 2.51760403 |
| 104 | heart trabecula formation (GO:0060347) | 2.51718947 |
| 105 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 2.51531103 |
| 106 | regulation of tight junction assembly (GO:2000810) | 2.51505567 |
| 107 | regulation of gamma-delta T cell activation (GO:0046643) | 2.51180717 |
| 108 | negative regulation of cartilage development (GO:0061037) | 2.50768207 |
| 109 | actin filament-based movement (GO:0030048) | 2.49081347 |
| 110 | skeletal muscle contraction (GO:0003009) | 2.48613476 |
| 111 | adherens junction assembly (GO:0034333) | 2.48333846 |
| 112 | biotin metabolic process (GO:0006768) | 2.47404981 |
| 113 | detection of external biotic stimulus (GO:0098581) | 2.46204054 |
| 114 | barbed-end actin filament capping (GO:0051016) | 2.45859878 |
| 115 | tricarboxylic acid metabolic process (GO:0072350) | 2.44747123 |
| 116 | retinoic acid receptor signaling pathway (GO:0048384) | 2.44700912 |
| 117 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.44648083 |
| 118 | NADH metabolic process (GO:0006734) | 2.44523568 |
| 119 | regulation of the force of heart contraction (GO:0002026) | 2.43177434 |
| 120 | germinal center formation (GO:0002467) | 2.39885380 |
| 121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.39503947 |
| 122 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.34552558 |
| 123 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.31835326 |
| 124 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.30389011 |
| 125 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.29850347 |
| 126 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.28592719 |
| 127 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.28592719 |
| 128 | modulation by symbiont of host immune response (GO:0052553) | 2.28592719 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.28592719 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.28592719 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.28592719 |
| 132 | positive regulation of Rap GTPase activity (GO:0032854) | 2.27105650 |
| 133 | detection of molecule of bacterial origin (GO:0032490) | 2.23955296 |
| 134 | response to epinephrine (GO:0071871) | 2.21355554 |
| 135 | regulation of ARF GTPase activity (GO:0032312) | 2.20247877 |
| 136 | macrophage activation involved in immune response (GO:0002281) | 2.19992897 |
| 137 | negative regulation of type 2 immune response (GO:0002829) | 2.19822207 |
| 138 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.15005224 |
| 139 | regulation of macrophage cytokine production (GO:0010935) | 2.11966229 |
| 140 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.10969881 |
| 141 | response to laminar fluid shear stress (GO:0034616) | 2.09568121 |
| 142 | fibril organization (GO:0097435) | 2.08638588 |
| 143 | regulation of platelet aggregation (GO:0090330) | 2.08025645 |
| 144 | positive thymic T cell selection (GO:0045059) | 2.07805754 |
| 145 | leukocyte aggregation (GO:0070486) | 2.07625973 |
| 146 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.07622606 |
| 147 | neutrophil activation involved in immune response (GO:0002283) | 2.05959790 |
| 148 | regulation of necroptotic process (GO:0060544) | 2.04342860 |
| 149 | detection of biotic stimulus (GO:0009595) | 2.03413251 |
| 150 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.03215211 |
| 151 | cellular response to monoamine stimulus (GO:0071868) | 2.01700160 |
| 152 | cellular response to catecholamine stimulus (GO:0071870) | 2.01700160 |
| 153 | regulation of mast cell degranulation (GO:0043304) | 2.01442122 |
| 154 | regulation of leukocyte degranulation (GO:0043300) | 2.01219799 |
| 155 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.01103698 |
| 156 | protein targeting to plasma membrane (GO:0072661) | 2.00651343 |
| 157 | response to muramyl dipeptide (GO:0032495) | 2.00605869 |
| 158 | cellular extravasation (GO:0045123) | 2.00471143 |
| 159 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 1.97904003 |
| 160 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 1.97322946 |
| 161 | regulation of type 2 immune response (GO:0002828) | 1.97300239 |
| 162 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 1.94659850 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 1.93665482 |
| 164 | regulation of Rap GTPase activity (GO:0032317) | 1.91983425 |
| 165 | extracellular fibril organization (GO:0043206) | 1.91006108 |
| 166 | regulation of tolerance induction (GO:0002643) | 1.90941320 |
| 167 | activation of protein kinase A activity (GO:0034199) | 1.89845937 |
| 168 | thymic T cell selection (GO:0045061) | 1.89385673 |
| 169 | response to type I interferon (GO:0034340) | 1.87873765 |
| 170 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 1.87836039 |
| 171 | regulation of beta-amyloid formation (GO:1902003) | 1.87826499 |
| 172 | negative thymic T cell selection (GO:0045060) | 1.87787696 |
| 173 | positive regulation of macrophage cytokine production (GO:0060907) | 1.87722764 |
| 174 | type I interferon signaling pathway (GO:0060337) | 1.87489346 |
| 175 | cellular response to type I interferon (GO:0071357) | 1.87489346 |
| 176 | extracellular matrix assembly (GO:0085029) | 1.87203635 |
| 177 | hypotonic response (GO:0006971) | 1.86930421 |
| 178 | positive regulation of cholesterol efflux (GO:0010875) | 1.86876211 |
| 179 | B cell receptor signaling pathway (GO:0050853) | 1.86472326 |
| 180 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.86216934 |
| 181 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 1.86192215 |
| 182 | positive regulation of tolerance induction (GO:0002645) | 1.86123790 |
| 183 | negative regulation of myotube differentiation (GO:0010832) | 1.85806357 |
| 184 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 1.85418231 |
| 185 | regulation of T cell tolerance induction (GO:0002664) | 1.85228577 |
| 186 | negative regulation of stress fiber assembly (GO:0051497) | 1.84105519 |
| 187 | macroautophagy (GO:0016236) | 1.83753462 |
| 188 | response to fluid shear stress (GO:0034405) | 1.82730861 |
| 189 | response to interleukin-15 (GO:0070672) | 1.82425160 |
| 190 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 1.82206518 |
| 191 | negative regulation of T-helper cell differentiation (GO:0045623) | 1.82206518 |
| 192 | positive regulation of type 2 immune response (GO:0002830) | 1.82202008 |
| 193 | positive T cell selection (GO:0043368) | 1.81822857 |
| 194 | T cell selection (GO:0045058) | 1.81808009 |
| 195 | regulation of mast cell activation involved in immune response (GO:0033006) | 1.80811730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.06578837 |
| 2 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.69486957 |
| 3 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.58588035 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51920385 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.51367112 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40273474 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34903711 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.30833676 |
| 9 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.26593195 |
| 10 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24995973 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12562120 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06802271 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.06659362 |
| 14 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.04343740 |
| 15 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.03929512 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03920270 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00463070 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.99267966 |
| 19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.98122409 |
| 20 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.92575325 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.87642620 |
| 22 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.84876578 |
| 23 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.84768660 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81713359 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.77102500 |
| 26 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.75544070 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75441609 |
| 28 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.74766542 |
| 29 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73234488 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73134527 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73042818 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72614410 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.72325602 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.72154228 |
| 35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.71082953 |
| 36 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.70544306 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68317378 |
| 38 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.68209189 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.64905336 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64640594 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63221560 |
| 42 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.62390771 |
| 43 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.61689369 |
| 44 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.61689369 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60070185 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.59263433 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.58156947 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57449533 |
| 49 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.55269039 |
| 50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.54018514 |
| 51 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53342898 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53295506 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52884497 |
| 54 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.51213954 |
| 55 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.50909880 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50273739 |
| 57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.49276887 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48182805 |
| 59 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46043982 |
| 60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.43940489 |
| 61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42873725 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42268606 |
| 63 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.40824862 |
| 64 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40495401 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39046633 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35741462 |
| 67 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35100722 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.34067875 |
| 69 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33972920 |
| 70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.33915146 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.32767017 |
| 72 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.31646521 |
| 73 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.31509130 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31175380 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29759147 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29687270 |
| 77 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28606865 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28215205 |
| 79 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.28176321 |
| 80 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27834129 |
| 81 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27051558 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 1.26616511 |
| 83 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25655340 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25508422 |
| 85 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.25486549 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24946185 |
| 87 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22015280 |
| 88 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.21824929 |
| 89 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21559969 |
| 90 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21410928 |
| 91 | * MYC_22102868_ChIP-Seq_BL_Human | 1.21171535 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20868863 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20561632 |
| 94 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.20499372 |
| 95 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.20338985 |
| 96 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.20338985 |
| 97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.20338985 |
| 98 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20106656 |
| 99 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.19248959 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16732176 |
| 101 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16614516 |
| 102 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.16128015 |
| 103 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15584125 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.15215481 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14349242 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13630643 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.13044658 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.12974165 |
| 109 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.11752854 |
| 110 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11708439 |
| 111 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11695138 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11658648 |
| 113 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10619382 |
| 114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09866751 |
| 115 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09848779 |
| 116 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08092571 |
| 117 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.08005078 |
| 118 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.07992192 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07963644 |
| 120 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06821364 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05405855 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05239438 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04324553 |
| 124 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.04281317 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.04273595 |
| 126 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04098303 |
| 127 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03694180 |
| 128 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03190556 |
| 129 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03121313 |
| 130 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.02817627 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.01883546 |
| 132 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01698155 |
| 133 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01547274 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01406294 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01325344 |
| 136 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.01105269 |
| 137 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00860835 |
| 138 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00774992 |
| 139 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.00610382 |
| 140 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00595659 |
| 141 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99339791 |
| 142 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99247972 |
| 143 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98829957 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97901047 |
| 145 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97603998 |
| 146 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97177519 |
| 147 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96760576 |
| 148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96305502 |
| 149 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95894390 |
| 150 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.90151033 |
| 151 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89991845 |
| 152 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89318371 |
| 153 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89041136 |
| 154 | MAF_26560356_Chip-Seq_TH2_Human | 0.88846248 |
| 155 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87301872 |
| 156 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.86990380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 4.41155798 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.28852295 |
| 3 | MP0004233_abnormal_muscle_weight | 3.54640525 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.12141140 |
| 5 | MP0003724_increased_susceptibility_to | 2.99007660 |
| 6 | MP0004130_abnormal_muscle_cell | 2.91607763 |
| 7 | MP0005330_cardiomyopathy | 2.76049170 |
| 8 | MP0003646_muscle_fatigue | 2.63683624 |
| 9 | MP0004087_abnormal_muscle_fiber | 2.61444640 |
| 10 | MP0002269_muscular_atrophy | 2.60111272 |
| 11 | MP0009278_abnormal_bone_marrow | 2.58511846 |
| 12 | MP0003436_decreased_susceptibility_to | 2.53354379 |
| 13 | MP0010030_abnormal_orbit_morphology | 2.48431203 |
| 14 | MP0000749_muscle_degeneration | 2.42630733 |
| 15 | MP0003303_peritoneal_inflammation | 2.41999629 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.35173620 |
| 17 | MP0003283_abnormal_digestive_organ | 2.34331101 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.27359621 |
| 19 | MP0010630_abnormal_cardiac_muscle | 2.18420324 |
| 20 | MP0004215_abnormal_myocardial_fiber | 2.16365343 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.16271471 |
| 22 | MP0003137_abnormal_impulse_conducting | 2.11203079 |
| 23 | MP0002106_abnormal_muscle_physiology | 2.02409451 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.99753894 |
| 25 | MP0004145_abnormal_muscle_electrophysio | 1.97946489 |
| 26 | MP0000759_abnormal_skeletal_muscle | 1.94305666 |
| 27 | MP0005503_abnormal_tendon_morphology | 1.90107274 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.89698981 |
| 29 | MP0004510_myositis | 1.84281407 |
| 30 | MP0000747_muscle_weakness | 1.84183887 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.80214633 |
| 32 | MP0005666_abnormal_adipose_tissue | 1.76841447 |
| 33 | MP0008260_abnormal_autophagy | 1.75082255 |
| 34 | MP0005369_muscle_phenotype | 1.73776778 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.72930928 |
| 36 | MP0003690_abnormal_glial_cell | 1.72356958 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.66846478 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.66530010 |
| 39 | MP0003329_amyloid_beta_deposits | 1.65292995 |
| 40 | MP0005670_abnormal_white_adipose | 1.64903343 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.61146015 |
| 42 | MP0002419_abnormal_innate_immunity | 1.58995996 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.58134263 |
| 44 | MP0005171_absent_coat_pigmentation | 1.57767044 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.55695355 |
| 46 | MP0003828_pulmonary_edema | 1.53647476 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.53609583 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.52826642 |
| 49 | MP0001544_abnormal_cardiovascular_syste | 1.52478115 |
| 50 | MP0005385_cardiovascular_system_phenoty | 1.52478115 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.51810251 |
| 52 | MP0003045_fibrosis | 1.50687464 |
| 53 | MP0002909_abnormal_adrenal_gland | 1.49315705 |
| 54 | MP0004947_skin_inflammation | 1.48736182 |
| 55 | MP0002108_abnormal_muscle_morphology | 1.47133849 |
| 56 | MP0005451_abnormal_body_composition | 1.46533853 |
| 57 | MP0002972_abnormal_cardiac_muscle | 1.46334864 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.45803642 |
| 59 | MP0005025_abnormal_response_to | 1.43974572 |
| 60 | MP0003091_abnormal_cell_migration | 1.42716487 |
| 61 | MP0005387_immune_system_phenotype | 1.42232872 |
| 62 | MP0001790_abnormal_immune_system | 1.42232872 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 1.40927261 |
| 64 | MP0006138_congestive_heart_failure | 1.40718537 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.39832806 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.38843429 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.38371870 |
| 68 | MP0000604_amyloidosis | 1.34492778 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.33084054 |
| 70 | MP0005076_abnormal_cell_differentiation | 1.30671430 |
| 71 | MP0001851_eye_inflammation | 1.26057263 |
| 72 | MP0000733_abnormal_muscle_development | 1.25205943 |
| 73 | MP0000685_abnormal_immune_system | 1.24989035 |
| 74 | MP0003763_abnormal_thymus_physiology | 1.24970412 |
| 75 | MP0002933_joint_inflammation | 1.24620573 |
| 76 | MP0008004_abnormal_stomach_pH | 1.24613182 |
| 77 | MP0001800_abnormal_humoral_immune | 1.20717085 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.20457213 |
| 79 | MP0006082_CNS_inflammation | 1.20038720 |
| 80 | MP0000579_abnormal_nail_morphology | 1.19679773 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 1.16746816 |
| 82 | MP0003879_abnormal_hair_cell | 1.16405629 |
| 83 | MP0003075_altered_response_to | 1.14117243 |
| 84 | MP0005275_abnormal_skin_tensile | 1.13482109 |
| 85 | MP0005409_darkened_coat_color | 1.12973845 |
| 86 | MP0002332_abnormal_exercise_endurance | 1.12932571 |
| 87 | MP0003567_abnormal_fetal_cardiomyocyte | 1.12115648 |
| 88 | MP0008995_early_reproductive_senescence | 1.11161625 |
| 89 | MP0002723_abnormal_immune_serum | 1.10834179 |
| 90 | MP0005388_respiratory_system_phenotype | 1.10297741 |
| 91 | MP0002133_abnormal_respiratory_system | 1.10297741 |
| 92 | MP0003279_aneurysm | 1.10115470 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 1.08930749 |
| 94 | MP0009785_altered_susceptibility_to | 1.08288236 |
| 95 | MP0002009_preneoplasia | 1.07901189 |
| 96 | MP0002249_abnormal_larynx_morphology | 1.07561571 |
| 97 | MP0002971_abnormal_brown_adipose | 1.06688931 |
| 98 | MP0005058_abnormal_lysosome_morphology | 1.06682819 |
| 99 | MP0002420_abnormal_adaptive_immunity | 1.06329882 |
| 100 | MP0004883_abnormal_blood_vessel | 1.05738141 |
| 101 | MP0003119_abnormal_digestive_system | 1.05709519 |
| 102 | MP0000266_abnormal_heart_morphology | 1.05421349 |
| 103 | MP0000920_abnormal_myelination | 1.03950264 |
| 104 | MP0001819_abnormal_immune_cell | 1.03701245 |
| 105 | MP0005365_abnormal_bile_salt | 1.03215276 |
| 106 | MP0005671_abnormal_response_to | 1.01351472 |
| 107 | MP0004085_abnormal_heartbeat | 1.01063672 |
| 108 | MP0005164_abnormal_response_to | 1.01057884 |
| 109 | MP0004133_heterotaxia | 1.00283950 |
| 110 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99447454 |
| 111 | MP0002405_respiratory_system_inflammati | 0.99215918 |
| 112 | MP0000249_abnormal_blood_vessel | 0.98915218 |
| 113 | MP0002452_abnormal_antigen_presenting | 0.98871658 |
| 114 | MP0002796_impaired_skin_barrier | 0.98719312 |
| 115 | MP0005390_skeleton_phenotype | 0.98597512 |
| 116 | MP0000767_abnormal_smooth_muscle | 0.98467962 |
| 117 | MP0003183_abnormal_peptide_metabolism | 0.97570536 |
| 118 | MP0005166_decreased_susceptibility_to | 0.97032591 |
| 119 | MP0010155_abnormal_intestine_physiology | 0.95513145 |
| 120 | MP0002234_abnormal_pharynx_morphology | 0.95218495 |
| 121 | MP0008569_lethality_at_weaning | 0.93535169 |
| 122 | MP0001849_ear_inflammation | 0.92490791 |
| 123 | MP0002127_abnormal_cardiovascular_syste | 0.91721041 |
| 124 | MP0009115_abnormal_fat_cell | 0.91124735 |
| 125 | MP0000858_altered_metastatic_potential | 0.90183958 |
| 126 | MP0000639_abnormal_adrenal_gland | 0.89684151 |
| 127 | MP0008874_decreased_physiological_sensi | 0.89436294 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.88691140 |
| 129 | MP0005023_abnormal_wound_healing | 0.87530158 |
| 130 | MP0004484_altered_response_of | 0.87450695 |
| 131 | MP0003172_abnormal_lysosome_physiology | 0.86900608 |
| 132 | MP0009384_cardiac_valve_regurgitation | 0.84341078 |
| 133 | MP0006072_abnormal_retinal_apoptosis | 0.84315916 |
| 134 | MP0001545_abnormal_hematopoietic_system | 0.83992851 |
| 135 | MP0005397_hematopoietic_system_phenotyp | 0.83992851 |
| 136 | MP0004381_abnormal_hair_follicle | 0.82874232 |
| 137 | MP0002282_abnormal_trachea_morphology | 0.82473119 |
| 138 | MP0009840_abnormal_foam_cell | 0.82396238 |
| 139 | MP0005085_abnormal_gallbladder_physiolo | 0.81336994 |
| 140 | MP0002060_abnormal_skin_morphology | 0.80910255 |
| 141 | MP0002148_abnormal_hypersensitivity_rea | 0.80842452 |
| 142 | MP0005535_abnormal_body_temperature | 0.79536423 |
| 143 | MP0009780_abnormal_chondrocyte_physiolo | 0.79508069 |
| 144 | MP0010352_gastrointestinal_tract_polyps | 0.78661605 |
| 145 | MP0005595_abnormal_vascular_smooth | 0.78199807 |
| 146 | MP0001542_abnormal_bone_strength | 0.77953694 |
| 147 | MP0004859_abnormal_synaptic_plasticity | 0.74765962 |
| 148 | MP0002925_abnormal_cardiovascular_devel | 0.73467967 |
| 149 | MP0003935_abnormal_craniofacial_develop | 0.73228705 |
| 150 | MP0004272_abnormal_basement_membrane | 0.71840672 |
| 151 | MP0005266_abnormal_metabolism | 0.71274921 |
| 152 | MP0001958_emphysema | 0.69655495 |
| 153 | MP0005508_abnormal_skeleton_morphology | 0.69346236 |
| 154 | MP0002970_abnormal_white_adipose | 0.68153832 |
| 155 | MP0000467_abnormal_esophagus_morphology | 0.68039233 |
| 156 | MP0004197_abnormal_fetal_growth/weight/ | 0.67208189 |
| 157 | MP0002084_abnormal_developmental_patter | 0.66106088 |
| 158 | MP0001784_abnormal_fluid_regulation | 0.65569170 |
| 159 | MP0002128_abnormal_blood_circulation | 0.64769838 |
| 160 | MP0002086_abnormal_extraembryonic_tissu | 0.63250268 |
| 161 | MP0000343_altered_response_to | 0.62755481 |
| 162 | MP0000762_abnormal_tongue_morphology | 0.60344707 |
| 163 | MP0010368_abnormal_lymphatic_system | 0.59536153 |
| 164 | MP0002118_abnormal_lipid_homeostasis | 0.59345474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.13116207 |
| 2 | Sudden death (HP:0001699) | 4.49820825 |
| 3 | Asymmetric septal hypertrophy (HP:0001670) | 3.97997233 |
| 4 | Hyporeflexia of lower limbs (HP:0002600) | 3.72677814 |
| 5 | Muscle fiber splitting (HP:0003555) | 3.69689927 |
| 6 | Myoglobinuria (HP:0002913) | 3.67171516 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.67013511 |
| 8 | Turricephaly (HP:0000262) | 3.65691694 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.64912083 |
| 10 | Ventricular tachycardia (HP:0004756) | 3.62277545 |
| 11 | Increased connective tissue (HP:0009025) | 3.47639229 |
| 12 | Exercise-induced muscle cramps (HP:0003710) | 3.43071124 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 3.40897338 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 3.33138350 |
| 15 | Difficulty running (HP:0009046) | 3.22321593 |
| 16 | Calf muscle hypertrophy (HP:0008981) | 3.20267743 |
| 17 | Aortic aneurysm (HP:0004942) | 3.14356083 |
| 18 | Increased IgE level (HP:0003212) | 3.11503314 |
| 19 | Annular pancreas (HP:0001734) | 3.05353238 |
| 20 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.99367954 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 2.99191432 |
| 22 | Obstructive sleep apnea (HP:0002870) | 2.98590695 |
| 23 | Large for gestational age (HP:0001520) | 2.98323532 |
| 24 | Difficulty climbing stairs (HP:0003551) | 2.91203742 |
| 25 | Ulnar bowing (HP:0003031) | 2.87418251 |
| 26 | Atrial fibrillation (HP:0005110) | 2.85969920 |
| 27 | Alopecia of scalp (HP:0002293) | 2.76582226 |
| 28 | Ketoacidosis (HP:0001993) | 2.75195894 |
| 29 | Polycythemia (HP:0001901) | 2.73241235 |
| 30 | Primary atrial arrhythmia (HP:0001692) | 2.73067213 |
| 31 | Myotonia (HP:0002486) | 2.69470265 |
| 32 | Bundle branch block (HP:0011710) | 2.68713876 |
| 33 | Rib fusion (HP:0000902) | 2.67494857 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.67118428 |
| 35 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.66372160 |
| 36 | Subaortic stenosis (HP:0001682) | 2.66372160 |
| 37 | Vascular tortuosity (HP:0004948) | 2.63181924 |
| 38 | Increased variability in muscle fiber diameter (HP:0003557) | 2.61206815 |
| 39 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.60328115 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.60256809 |
| 41 | Lipoatrophy (HP:0100578) | 2.58977249 |
| 42 | Supraventricular arrhythmia (HP:0005115) | 2.57797595 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 2.57692023 |
| 44 | Supraventricular tachycardia (HP:0004755) | 2.56553129 |
| 45 | Broad metatarsal (HP:0001783) | 2.54006064 |
| 46 | Hypercortisolism (HP:0001578) | 2.49815265 |
| 47 | Ventricular arrhythmia (HP:0004308) | 2.48011221 |
| 48 | Arterial tortuosity (HP:0005116) | 2.45322833 |
| 49 | Atrioventricular block (HP:0001678) | 2.44288239 |
| 50 | Hypoplastic ischia (HP:0003175) | 2.43754606 |
| 51 | Peritonitis (HP:0002586) | 2.42437491 |
| 52 | Diaphragmatic weakness (HP:0009113) | 2.41452280 |
| 53 | Myositis (HP:0100614) | 2.40949753 |
| 54 | Growth hormone excess (HP:0000845) | 2.39150205 |
| 55 | Distal lower limb muscle weakness (HP:0009053) | 2.38718952 |
| 56 | EMG: neuropathic changes (HP:0003445) | 2.37885576 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.36800106 |
| 58 | Aortic dissection (HP:0002647) | 2.36668448 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.32957412 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.31469765 |
| 61 | Recurrent bacterial skin infections (HP:0005406) | 2.31147932 |
| 62 | Gingivitis (HP:0000230) | 2.30834233 |
| 63 | Coronal craniosynostosis (HP:0004440) | 2.30819012 |
| 64 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.29313826 |
| 65 | Heart block (HP:0012722) | 2.29240495 |
| 66 | Syncope (HP:0001279) | 2.27437150 |
| 67 | Generalized amyotrophy (HP:0003700) | 2.26284933 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.25886934 |
| 69 | Neck muscle weakness (HP:0000467) | 2.25324224 |
| 70 | Male infertility (HP:0003251) | 2.23445996 |
| 71 | Neurofibrillary tangles (HP:0002185) | 2.23439989 |
| 72 | Bulbar palsy (HP:0001283) | 2.23162877 |
| 73 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.21926515 |
| 74 | Round ear (HP:0100830) | 2.21019390 |
| 75 | Abnormal atrioventricular conduction (HP:0005150) | 2.20392690 |
| 76 | Dilatation of the ascending aorta (HP:0005111) | 2.18987087 |
| 77 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.18248052 |
| 78 | Muscle fiber inclusion bodies (HP:0100299) | 2.17097614 |
| 79 | Abnormality of the ischium (HP:0003174) | 2.15836511 |
| 80 | Prolonged QT interval (HP:0001657) | 2.14508067 |
| 81 | Congenital hip dislocation (HP:0001374) | 2.11931345 |
| 82 | Orchitis (HP:0100796) | 2.11677882 |
| 83 | Purpura (HP:0000979) | 2.11347433 |
| 84 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.11173785 |
| 85 | Systemic lupus erythematosus (HP:0002725) | 2.10466226 |
| 86 | Aneurysm (HP:0002617) | 2.09289260 |
| 87 | Papilledema (HP:0001085) | 2.08144567 |
| 88 | Ventricular fibrillation (HP:0001663) | 2.07209387 |
| 89 | Ketosis (HP:0001946) | 2.06605007 |
| 90 | Epistaxis (HP:0000421) | 2.05177112 |
| 91 | Abnormality of the lower motor neuron (HP:0002366) | 2.04823422 |
| 92 | Palpitations (HP:0001962) | 2.04614801 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 2.04566166 |
| 94 | Dilated cardiomyopathy (HP:0001644) | 2.04444087 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03924766 |
| 96 | Rhabdomyolysis (HP:0003201) | 2.02449963 |
| 97 | Distal lower limb amyotrophy (HP:0008944) | 2.02268604 |
| 98 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01677556 |
| 99 | Mucopolysacchariduria (HP:0008155) | 2.01677556 |
| 100 | Emphysema (HP:0002097) | 1.98930662 |
| 101 | Abnormality of the neuromuscular junction (HP:0003398) | 1.97181740 |
| 102 | Fatigable weakness (HP:0003473) | 1.97181740 |
| 103 | Vertebral compression fractures (HP:0002953) | 1.96929608 |
| 104 | Popliteal pterygium (HP:0009756) | 1.96775302 |
| 105 | Abnormality of the nasal mucosa (HP:0000433) | 1.96669016 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 1.96304305 |
| 107 | Gingival bleeding (HP:0000225) | 1.96215835 |
| 108 | Protrusio acetabuli (HP:0003179) | 1.95556309 |
| 109 | Lymphangioma (HP:0100764) | 1.95144446 |
| 110 | Ulnar deviation of the wrist (HP:0003049) | 1.94040407 |
| 111 | Abnormality of binocular vision (HP:0011514) | 1.93505769 |
| 112 | Diplopia (HP:0000651) | 1.93505769 |
| 113 | Cervical subluxation (HP:0003308) | 1.92610684 |
| 114 | Supranuclear gaze palsy (HP:0000605) | 1.91063845 |
| 115 | Nemaline bodies (HP:0003798) | 1.89792197 |
| 116 | Narrow nasal bridge (HP:0000446) | 1.89453072 |
| 117 | Muscle stiffness (HP:0003552) | 1.89142596 |
| 118 | Gowers sign (HP:0003391) | 1.89001880 |
| 119 | Premature skin wrinkling (HP:0100678) | 1.88367650 |
| 120 | Abnormal EKG (HP:0003115) | 1.87472959 |
| 121 | Abnormality of the aortic arch (HP:0012303) | 1.87394842 |
| 122 | Hamartoma of the eye (HP:0010568) | 1.86138112 |
| 123 | Muscle fibrillation (HP:0010546) | 1.85689287 |
| 124 | Broad face (HP:0000283) | 1.85674232 |
| 125 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85239834 |
| 126 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85239834 |
| 127 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85239834 |
| 128 | Ankle contracture (HP:0006466) | 1.84877934 |
| 129 | Cellulitis (HP:0100658) | 1.84133987 |
| 130 | Neoplasm of the heart (HP:0100544) | 1.83595001 |
| 131 | Bowing of the arm (HP:0006488) | 1.83288074 |
| 132 | Bowed forearm bones (HP:0003956) | 1.83288074 |
| 133 | Amyloidosis (HP:0011034) | 1.82735403 |
| 134 | Concave nail (HP:0001598) | 1.80989322 |
| 135 | Myopathic facies (HP:0002058) | 1.80557024 |
| 136 | Spondylolisthesis (HP:0003302) | 1.78739699 |
| 137 | Chest pain (HP:0100749) | 1.77543188 |
| 138 | Premature rupture of membranes (HP:0001788) | 1.77180396 |
| 139 | Testicular atrophy (HP:0000029) | 1.76552370 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76092313 |
| 141 | Dysmetric saccades (HP:0000641) | 1.75921643 |
| 142 | Foot dorsiflexor weakness (HP:0009027) | 1.75625814 |
| 143 | Scapular winging (HP:0003691) | 1.75555580 |
| 144 | Dysostosis multiplex (HP:0000943) | 1.75287950 |
| 145 | Hamartoma (HP:0010566) | 1.75144988 |
| 146 | Nasal polyposis (HP:0100582) | 1.74881479 |
| 147 | Spinal rigidity (HP:0003306) | 1.74799999 |
| 148 | Onion bulb formation (HP:0003383) | 1.74650685 |
| 149 | Anteriorly placed anus (HP:0001545) | 1.74321723 |
| 150 | Ankle clonus (HP:0011448) | 1.72665650 |
| 151 | Rapidly progressive (HP:0003678) | 1.71586980 |
| 152 | Optic neuritis (HP:0100653) | 1.71334685 |
| 153 | Retrobulbar optic neuritis (HP:0100654) | 1.71334685 |
| 154 | Abnormality of the fingertips (HP:0001211) | 1.70889732 |
| 155 | Wormian bones (HP:0002645) | 1.69796300 |
| 156 | Colitis (HP:0002583) | 1.67547989 |
| 157 | Hypoplasia of the iris (HP:0007676) | 1.67196462 |
| 158 | Abnormality of the foot musculature (HP:0001436) | 1.63998765 |
| 159 | Striae distensae (HP:0001065) | 1.63751974 |
| 160 | Hypertriglyceridemia (HP:0002155) | 1.61962375 |
| 161 | Lower limb amyotrophy (HP:0007210) | 1.60369631 |
| 162 | Atrophic scars (HP:0001075) | 1.59421943 |
| 163 | Inflammation of the large intestine (HP:0002037) | 1.57985582 |
| 164 | Hemorrhage of the eye (HP:0011885) | 1.57729162 |
| 165 | Menorrhagia (HP:0000132) | 1.56880753 |
| 166 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.56115827 |
| 167 | Gastrointestinal inflammation (HP:0004386) | 1.55610870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 4.52335535 |
| 2 | TRIB3 | 3.85886645 |
| 3 | DDR2 | 3.74761985 |
| 4 | MAPK15 | 3.10557873 |
| 5 | PDGFRA | 2.86441462 |
| 6 | TTN | 2.72818162 |
| 7 | PINK1 | 2.69532299 |
| 8 | RIPK4 | 2.61176950 |
| 9 | TYRO3 | 2.53274928 |
| 10 | PHKG2 | 2.47481928 |
| 11 | PHKG1 | 2.47481928 |
| 12 | MAP3K6 | 2.38252897 |
| 13 | RIPK1 | 2.10288514 |
| 14 | MAP3K11 | 1.94659066 |
| 15 | DYRK1B | 1.81826003 |
| 16 | TYK2 | 1.81404286 |
| 17 | MAP2K3 | 1.81330544 |
| 18 | PRKD2 | 1.72362193 |
| 19 | MAP4K1 | 1.70769436 |
| 20 | BMX | 1.69815715 |
| 21 | DMPK | 1.69157051 |
| 22 | PKN2 | 1.62684788 |
| 23 | ZAP70 | 1.61055810 |
| 24 | SIK1 | 1.60696080 |
| 25 | MATK | 1.60439093 |
| 26 | FGR | 1.54161072 |
| 27 | BLK | 1.50990684 |
| 28 | TNK2 | 1.48934750 |
| 29 | FES | 1.46444029 |
| 30 | DAPK1 | 1.45518089 |
| 31 | UHMK1 | 1.42849799 |
| 32 | LMTK2 | 1.37794550 |
| 33 | MAP3K13 | 1.37596156 |
| 34 | JAK1 | 1.36364400 |
| 35 | BCKDK | 1.33323759 |
| 36 | CDC42BPA | 1.31863466 |
| 37 | MAP3K3 | 1.26650481 |
| 38 | TRPM7 | 1.24168224 |
| 39 | EPHA3 | 1.23163701 |
| 40 | MAP3K10 | 1.21159627 |
| 41 | CSK | 1.20070736 |
| 42 | JAK3 | 1.13708783 |
| 43 | LATS2 | 1.13407524 |
| 44 | ERN1 | 1.12787711 |
| 45 | OBSCN | 1.09252070 |
| 46 | TBK1 | 1.06812375 |
| 47 | MAPK7 | 1.05967907 |
| 48 | GRK6 | 1.05015555 |
| 49 | PDK4 | 1.04029638 |
| 50 | PDK3 | 1.04029638 |
| 51 | PIK3CG | 1.03421254 |
| 52 | MAPK11 | 1.02174766 |
| 53 | MAP3K1 | 1.01943715 |
| 54 | NEK1 | 1.00382076 |
| 55 | MAPKAPK3 | 0.97989721 |
| 56 | RPS6KL1 | 0.97180942 |
| 57 | RPS6KC1 | 0.97180942 |
| 58 | STK38 | 0.96121986 |
| 59 | HCK | 0.95871993 |
| 60 | PDPK1 | 0.93770457 |
| 61 | PRKAA1 | 0.93582557 |
| 62 | MTOR | 0.93421071 |
| 63 | JAK2 | 0.91587044 |
| 64 | PRKD1 | 0.91316120 |
| 65 | BTK | 0.90867686 |
| 66 | CDK6 | 0.90536582 |
| 67 | SGK3 | 0.87025587 |
| 68 | CAMKK1 | 0.86218243 |
| 69 | PRKD3 | 0.85403497 |
| 70 | TESK1 | 0.85389903 |
| 71 | PDK1 | 0.85087546 |
| 72 | SYK | 0.83935031 |
| 73 | MYLK | 0.83446982 |
| 74 | RPS6KA6 | 0.82549419 |
| 75 | PDGFRB | 0.80700759 |
| 76 | TAOK1 | 0.80589969 |
| 77 | MAP3K7 | 0.80007761 |
| 78 | PTK2 | 0.79835884 |
| 79 | RPS6KA2 | 0.79192730 |
| 80 | PTK2B | 0.76940151 |
| 81 | TXK | 0.76597586 |
| 82 | FGFR3 | 0.76543024 |
| 83 | SGK2 | 0.75062561 |
| 84 | EEF2K | 0.74796412 |
| 85 | MAP3K9 | 0.73999432 |
| 86 | SGK223 | 0.73012894 |
| 87 | SGK494 | 0.73012894 |
| 88 | IKBKE | 0.72014889 |
| 89 | PTK6 | 0.71643004 |
| 90 | FGFR4 | 0.71513789 |
| 91 | GSK3A | 0.71437287 |
| 92 | KIT | 0.70238034 |
| 93 | PIM2 | 0.67968483 |
| 94 | WNK1 | 0.66617025 |
| 95 | MARK1 | 0.66546894 |
| 96 | NEK9 | 0.65513005 |
| 97 | HIPK2 | 0.65016868 |
| 98 | IRAK4 | 0.64979900 |
| 99 | CAMK1 | 0.64164483 |
| 100 | CAMK1D | 0.63400434 |
| 101 | ITK | 0.62662297 |
| 102 | FYN | 0.62336452 |
| 103 | TIE1 | 0.62229538 |
| 104 | DAPK2 | 0.61580310 |
| 105 | RPS6KA1 | 0.61059770 |
| 106 | LATS1 | 0.60984436 |
| 107 | PRKAA2 | 0.60352335 |
| 108 | AKT3 | 0.60267857 |
| 109 | CDK12 | 0.60065540 |
| 110 | PAK6 | 0.59638067 |
| 111 | MAP3K14 | 0.56621177 |
| 112 | FLT3 | 0.56145028 |
| 113 | ILK | 0.54984177 |
| 114 | PAK3 | 0.54852568 |
| 115 | PRKCH | 0.54792680 |
| 116 | FGFR1 | 0.54709481 |
| 117 | LCK | 0.54368803 |
| 118 | NTRK3 | 0.53179086 |
| 119 | MAPK4 | 0.52678945 |
| 120 | MARK2 | 0.52268685 |
| 121 | TGFBR2 | 0.50947749 |
| 122 | CSF1R | 0.50613156 |
| 123 | PDK2 | 0.48954907 |
| 124 | EPHB1 | 0.48929211 |
| 125 | FGFR2 | 0.48539534 |
| 126 | TAOK2 | 0.46390272 |
| 127 | MAP2K4 | 0.45949935 |
| 128 | GRK5 | 0.45846619 |
| 129 | DAPK3 | 0.44185008 |
| 130 | CAMK1G | 0.43609350 |
| 131 | PRPF4B | 0.43531433 |
| 132 | EPHB2 | 0.43400504 |
| 133 | CAMK4 | 0.43159079 |
| 134 | FER | 0.39035021 |
| 135 | PAK2 | 0.37690322 |
| 136 | CAMK2D | 0.37473388 |
| 137 | NTRK1 | 0.37236296 |
| 138 | RET | 0.35863131 |
| 139 | SIK2 | 0.35543675 |
| 140 | CAMK2G | 0.35500905 |
| 141 | SGK1 | 0.34870172 |
| 142 | KSR2 | 0.33997638 |
| 143 | MAPK12 | 0.33095777 |
| 144 | LRRK2 | 0.31876764 |
| 145 | NTRK2 | 0.31121361 |
| 146 | RPS6KA3 | 0.30989726 |
| 147 | PIM1 | 0.30624508 |
| 148 | ROCK1 | 0.30510371 |
| 149 | CDK7 | 0.29195170 |
| 150 | PAK4 | 0.28769780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.76007119 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.54546667 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.33673783 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.51872365 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.46935199 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.11833543 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.91122632 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.88581442 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86054146 |
| 10 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.77518605 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.72463050 |
| 12 | Circadian rhythm_Homo sapiens_hsa04710 | 1.70123014 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68028178 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.67259014 |
| 15 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.62543678 |
| 16 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.58368116 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.51698061 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50864354 |
| 19 | Lysine degradation_Homo sapiens_hsa00310 | 1.50091451 |
| 20 | Adherens junction_Homo sapiens_hsa04520 | 1.48408282 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47258992 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43652652 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37430542 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.35611559 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35526855 |
| 26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.35525193 |
| 27 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.34895530 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31483733 |
| 29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.30645519 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30087924 |
| 31 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.28891666 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.28078534 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.24495766 |
| 34 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.23909299 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22833934 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20398844 |
| 37 | Focal adhesion_Homo sapiens_hsa04510 | 1.19871419 |
| 38 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.18223289 |
| 39 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.17825674 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.16937040 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16620805 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15759311 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 1.13330549 |
| 44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.13161349 |
| 45 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.12350723 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12318217 |
| 47 | Long-term potentiation_Homo sapiens_hsa04720 | 1.11583098 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.10079555 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07670925 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.06615281 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05846668 |
| 52 | Tight junction_Homo sapiens_hsa04530 | 1.04649364 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02802968 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02322916 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01307435 |
| 56 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.01306581 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00993790 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00309762 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00014493 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99794816 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.99026386 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98850434 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98528669 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97625870 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96966105 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95293230 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.94936753 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92681052 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89888765 |
| 70 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89395546 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.88938410 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87576690 |
| 73 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87054657 |
| 74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86614602 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85709229 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84958477 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83608386 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.83477468 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.82942059 |
| 80 | Gap junction_Homo sapiens_hsa04540 | 0.82122723 |
| 81 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80011492 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79977786 |
| 83 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79954903 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.79621188 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79391095 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78745100 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.78493011 |
| 88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76798141 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76692057 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.76568890 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76523071 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75788515 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.74413941 |
| 94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74220909 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72754899 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72675915 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72439755 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72057195 |
| 99 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71930487 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70325276 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69646610 |
| 102 | Influenza A_Homo sapiens_hsa05164 | 0.69507836 |
| 103 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68013338 |
| 104 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.67935819 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67899197 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67562839 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.66620670 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.66543839 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66477621 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.65772259 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65711261 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65133331 |
| 113 | Insulin secretion_Homo sapiens_hsa04911 | 0.64707699 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.64557013 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63988418 |
| 116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.63984672 |
| 117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.63340249 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63227475 |
| 119 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.63211287 |
| 120 | Measles_Homo sapiens_hsa05162 | 0.63043026 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.62671420 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62657300 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.60258056 |
| 124 | Olfactory transduction_Homo sapiens_hsa04740 | 0.60126902 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60116097 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.58795507 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58395883 |
| 128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57280852 |
| 129 | Glioma_Homo sapiens_hsa05214 | 0.57272680 |
| 130 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53182809 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53044300 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.52762367 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52672435 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52108067 |
| 135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51915349 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49385248 |
| 137 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.49220143 |
| 138 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48700357 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48507889 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48228689 |
| 141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47230668 |
| 142 | Melanogenesis_Homo sapiens_hsa04916 | 0.46559513 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46164394 |
| 144 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45957593 |
| 145 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45839826 |
| 146 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45099196 |
| 147 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44074502 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.43206005 |
| 149 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42288724 |
| 150 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41432022 |
| 151 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38979464 |
| 152 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38907089 |
| 153 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38088545 |

